Results 1 to 10 of about 4,987,680 (307)

Combined electrospun fibre-microneedle patches for enhanced transmucosal delivery of benzodiazepines and proteins.

Biomater Sci
Berry C, Edmans JG, Slowik KM, Byers RA, Danby S, Hatton PV, Murdoch C, Colley HE.   +7 more
europepmc   +1 more source

Covalent grafting of hyaluronic acid on drug nanocrystals for mucosal delivery.

J Mater Chem B
Fuster MG, Fandiño OE, Ramesh A, Coulter JA, Paredes AJ.   +4 more
europepmc   +1 more source

Drug-Drug Interactions: Antiretroviral Drugs and Recreational Drugs

Recent Patents on CNS Drug Discovery, 2015
With the advances in antiretroviral (ARV) therapy, patients with Human Immunodeficiency Virus (HIV) infection are living longer, however, some patients encounter co- morbidities which sometimes require treatment. Therefore, during the treatment with ARV drugs these patients could take several recreational drugs (e.g.
Orietta, Staltari, Christian, Leporini, Benedetto, Caroleo, Emilio, Russo, Antonio, Siniscalchi, Giovambattista, De Sarro, Luca, Gallelli   +6 more
openaire   +2 more sources

Monitoring of Drug-Drug and Drug-Food Interactions

American Journal of Health-System Pharmacy, 1988
A program for detecting and preventing potentially serious drug-drug and drug-food interactions is described. Two clinical pharmacists developed drug interaction alert (DIA) cards for each potential interaction to be monitored. The cards contain information about the proposed mechanism and potential result of the interaction, as well as information ...
S M, Garabedian-Ruffalo, M, Syrja-Farber, P M, Lanius, A, Plucinski   +3 more
openaire   +2 more sources

Therapeutic Drug Monitoring and Drug–Drug Interactions Involving Antiretroviral Drugs

Antiviral Therapy, 2005
The consensus of current international guidelines for the treatment of HIV infection is that data on therapeutic drug monitoring (TDM) of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs) provide a framework for the implementation of TDM in certain defined scenarios in clinical practice.
Boffito, M, Acosta, E, Burger, D, Fletcher, C, Flexner, C, Garaffo, R, Gatti, G, Kurowski, M, PERNO, CARLO FEDERICO, Peytavin, G, Regazzi, M, Back, D.   +11 more
openaire   +4 more sources

Herb Drug Interaction in Antibiotic Drug, Antiulcer Drug, Antihypertensive Drug, Antidiabetic Drug, Anticancer Drug

Research Journal of Science and Technology, 2023
Sauces are frequently administered in combination with remedial medicines, raising the eventuality of condiment- medicine relations. An expansive review of the literature linked reported condiment- medicine relations with clinical significance, numerous of which are from case reports and limited clinical compliances. Cases have been published reporting
Chiatali O. Doke, Ranjit S. Tiwari, Vijay B. Todekar, Abhijeet P. Mane, Viraj S. Sawant, Ganesh V. Sawant   +5 more
openaire   +1 more source

Drug–drug interaction with statins

Expert Review of Clinical Pharmacology, 2008
3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase inhibitors (the so-called statins: atorvastatin, fluvastatin, pravastatin, lovastatin, rosuvastatin and simvastatin) are a well-established class of drugs in the treatment of hypercholesterolemia. Statin monotherapy is generally well tolerated, with a low frequency of adverse events.
A. Corsini, S. Bellosta
openaire   +2 more sources

Drug Repurposing Based on Drug–Drug Interaction

Chemical Biology & Drug Design, 2014
Given the high risk and lengthy procedure of traditional drug development, drug repurposing is gaining more and more attention. Although many types of drug information have been used to repurpose drugs, drug–drug interaction data, which imply possible physiological effects or targets of drugs, remain unexploited.
Bin, Zhou, Rong, Wang, Ping, Wu, De-Xin, Kong   +3 more
openaire   +2 more sources